Our client had a novel in vitro diagnostic test for detecting a marker for cervical cancer. The diagnostic test could be made available on a number of different platforms for use in clinical laboratories, histological analysis and point of care. The client wanted to understand the diagnostic pathway for the screening, diagnosis and management of cervical cancer to determine how the novel technology could be used to best effect.
We researched the Chemins cliniques/stratégies thérapeutiques in a number of European countries and identified those with the lowest barriers to entry. We supplemented this with clarifying the reimbursement position for the proposed products in the most attractive market segments.
We worked with our client to identify those markets that provided short term opportunities and those where the care pathway and in particular the existence of formal screening programmes would require long term programmes to access.
The company is using the information we provided to focus and target its marketing efforts to maximize its ROI.